David John Webb (David J Webb, D J Webb)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Venues

Science translational medicine

Toxicological sciences : an official journal of the Society of Toxicology

Nature reviews. Cardiology

British journal of clinical pharmacology

University of Edinburgh

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Edinburgh

United Kingdom

Christison Professor of Therapeutics and Clinical Pharmacology :: Clinical Pharmacology

University of Edinburgh

United Kingdom

Senior Lecturer in Medicine :: Medicine, Western General Hospital

Saint Georges, University of London

United Kingdom

Clinical Lecturer :: Department of Basic and Clinical Pharmacology

MRC Blood Pressure Unit

United Kingdom

Clinician Scientist :: Western Infirmary

Royal London Hospital

United Kingdom

Junior Medical Rotations :: Medicine

Publications

Kathleen M Scullion, Iain M MacIntyre, Sian Sloan-Dennison, Benjamin Clark, Paul Fineran, Joanne Mair, David Creasey, Cicely Rathmell, Karen Faulds, Duncan Graham, David John Webb, James W Dear
Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). Toxicological sciences : an official journal of the Society of Toxicology 199 (2) (2024)
Kathleen M Scullion, Iain M MacIntyre, Sian Sloan-Dennison, Benjamin Clark, Paul Fineran, Joanne Mair, David Creasey, Cicely Rathmell, Karen Faulds, Duncan Graham, David John Webb, James W Dear
Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). Toxicological sciences : an official journal of the Society of Toxicology 199 (2) (2024)
Kathleen M Scullion, Iain M MacIntyre, Sian Sloan-Dennison, Benjamin Clark, Paul Fineran, Joanne Mair, David Creasey, Cicely Rathmell, Karen Faulds, Duncan Graham, David John Webb, James W Dear
Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). Toxicological sciences : an official journal of the Society of Toxicology 199 (2) (2024)
Kathleen M Scullion, Iain M MacIntyre, Sian Sloan-Dennison, Benjamin Clark, Paul Fineran, Joanne Mair, David Creasey, Cicely Rathmell, Karen Faulds, Duncan Graham, David John Webb, James W Dear
Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). Toxicological sciences : an official journal of the Society of Toxicology 199 (2) (2024)
David John Webb
Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension. Cardiovascular research 120 (10) (2024)
Linsay McCallum, Stefanie Lip, Alexander McConnachie, Katriona Brooksbank, Iain M MacIntyre, Alexander S F Doney, Andrea Llano, Alisha Aman, Thomas M Caparrotta, Gareth Ingram, Isla S Mackenzie, Anna F Dominiczak, Thomas M MacDonald, David John Webb, Sandosh Padmanabhan
UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide. Hypertension (Dallas, Tex. : 1979) (2024)
Melisande L Addison, Priyanga Ranasinghe, David John Webb
Novel Pharmacological Approaches in the Treatment of Hypertension: A Focus on RNA-Based Therapeutics. Hypertension (Dallas, Tex. : 1979) (2023)
Tariq E Farrah, Dan Pugh, Fiona A Chapman, Emily Godden, Craig Balmforth, Gabriel C Oniscu, David John Webb, Baljean Dhillon, James W Dear, Matthew A Bailey, Peter J Gallacher, Neeraj Dhaun
Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment. Nature communications 14 (1) (2023)
Melisande L Addison, Priyanga Ranasinghe, David John Webb
Emerging insights and future prospects for therapeutic application of siRNA targeting angiotensinogen in hypertension. Expert review of clinical pharmacology (2023)
Priyanga Ranasinghe, Melisande L Addison, James W Dear, David John Webb
Small interfering RNA: Discovery, pharmacology and clinical development-An introductory review. British journal of pharmacology (2022)
Richard B Weller, Iain M MacIntyre, Vanessa Melville, Michael Farrugia, Martin Feelisch, David John Webb
The effect of daily UVA phototherapy for 2 weeks on clinic and 24-h blood pressure in individuals with mild hypertension. Journal of human hypertension (2022)
Alicja Czopek, Rebecca Moorhouse, Peter J Gallacher, Dan Pugh, Jessica R Ivy, Tariq E Farrah, Emily Godden, Robert W Hunter, David John Webb, Pierre-Louis Tharaux, David C Kluth, James W Dear, Matthew A Bailey, Neeraj Dhaun
Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice. Science translational medicine 14 (675) (2022)
Alicja Czopek, Rebecca Moorhouse, Peter J Gallacher, Dan Pugh, Jessica R Ivy, Tariq E Farrah, Emily Godden, Robert W Hunter, David John Webb, Pierre-Louis Tharaux, David C Kluth, James W Dear, Matthew A Bailey, Neeraj Dhaun
Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice. Science translational medicine 14 (675) (2022)
Priyanga Ranasinghe, Melisande L Addison, David John Webb
Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor-Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen-Targeting Small Interfering RNA. Journal of the American Heart Association 11 (20) (2022)
Iain M MacIntyre, Emma J Turtle, Tariq E Farrah, Catriona Graham, James W Dear, David John Webb, null null
Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial. Circulation 145 (6) (2022)
Alicja Czopek, Rebecca Moorhouse, Peter J Gallacher, Dan Pugh, Jessica R Ivy, Tariq E Farrah, Emily Godden, Robert W Hunter, David John Webb, Pierre-Louis Tharaux, David C Kluth, James W Dear, Matthew A Bailey, Neeraj Dhaun
Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice. Science translational medicine 14 (675) (2022)
Alicja Czopek, Rebecca Moorhouse, Peter J Gallacher, Dan Pugh, Jessica R Ivy, Tariq E Farrah, Emily Godden, Robert W Hunter, David John Webb, Pierre-Louis Tharaux, David C Kluth, James W Dear, Matthew A Bailey, Neeraj Dhaun
Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice. Science translational medicine 14 (675) (2022)
Alicja Czopek, Rebecca Moorhouse, Peter J Gallacher, Dan Pugh, Jessica R Ivy, Tariq E Farrah, Emily Godden, Robert W Hunter, David John Webb, Pierre-Louis Tharaux, David C Kluth, James W Dear, Matthew A Bailey, Neeraj Dhaun
Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice. Science translational medicine 14 (675) (2022)
Tariq E Farrah, David John Webb, Neeraj Dhaun
Retinal fingerprints for precision profiling of cardiovascular risk. Nature reviews. Cardiology 16 (7) (2020)
Neeraj Dhaun, David John Webb
Endothelins in cardiovascular biology and therapeutics. Nature reviews. Cardiology 16 (8) (2020)
Thomas M Caparrotta, James W Dear, Helen Martina Colhoun, David John Webb
Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making. British journal of clinical pharmacology 85 (9) (2019)
Iain McGregor MacIntyre, David John Webb
Renal denervation therapy for hypertension: still on trial. Heart (British Cardiac Society) 105 (19) (2019)
J C McCrae, E E Morrison, Iain M MacIntyre, James W Dear, David John Webb
Long-term adverse effects of paracetamol - a review. British journal of clinical pharmacology 84 (10) (2018)

David John Webb.css-eqlu8i{font-size:small;padding-left:4px;} (David J Webb, D J Webb)

Publication Activity (10 Years)

Top Topics

Top Venues

David John Webb (David J Webb, D J Webb)